Table 1.
Overview of patients’ characteristics.
| Characteristics | All Patients | Exploration Set (n = 138) |
Test Set (n = 138) |
p-Value | |||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| Age (years ± SD) | 69.9 ± 10.4 | 69.9 ± 10.9 | 70.1 ± 10.0 | NS | |||
| Follow-up (years ± SD) | 4.2 ± 2.39 | 4.0 ± 2.4 | 4.4 ± 2.4 | NS | |||
| Sex | NS | ||||||
| Female | 114 | 41.3% | 54 | 39.1% | 60 | 43.5% | |
| Male | 162 | 58.7% | 84 | 60.9% | 78 | 56.5% | |
| UICC | NS | ||||||
| I | 112 (40.5%) | 40.6% | 54 | 39.1% | 58 | 42.0% | |
| II | 164 (59.4%) | 59.4% | 84 | 60.9% | 80 | 58.0% | |
| pT | NS | ||||||
| 1 | 12 | 4.3% | 6 | 4.3% | 6 | 4.3% | |
| 2 | 100 | 36.2% | 48 | 34.8% | 52 | 37.7% | |
| 3 | 155 | 56.2% | 80 | 58.0% | 75 | 54.3% | |
| 4 | 9 | 3.3% | 4 | 2.9% | 5 | 3.6% | |
| Grading | NS | ||||||
| Low | 218 | 79.0% | 109 | 79.0% | 109 | 79.0% | |
| High | 58 | 21.0% | 29 | 21.0% | 29 | 21.0% | |
| Differentiation | 0.019 | ||||||
| Adenocarcinoma, NOS | 241 | 87.3% | 114 | 82.6% | 127 | 92.0% | |
| Specific Subtype | 35 | 12.7% | 24 | 17.4% | 11 | 8.0% | |
| Death | |||||||
| All causes | 102 | 37.0% | 48 | 34.8% | 54 | 39.1% | NS |
| Colon Cancer specific | 26 | 9.4% | 11 | 8.0% | 15 | 10.9% | NS |
| Distant Metastasis | NS | ||||||
| No | 245 | 88.8% | 126 | 91.3% | 119 | 86.2% | |
| Yes | 31 | 11.2% | 12 | 8.7% | 19 | 13.8% | |
UICC = Union Internationale Contre le Cancer, SD = standard deviation, NOS = no special type, NS = not significant.